FUNCTION OF WHITE BLOOD CELLS AND THEIR APOPTOTIC ACTIVITY IN PATIENTS WITH CHRONIC RENAL FAILURE ON HEMODYALISIS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The quantitative composition of white blood cells, their functional activity, the populations and subpopulations of peripheral blood lymphocytes, apoptosis of the latter when stained with fluorochrome-conjugated annexin V and 7-aminoactinomycin D by flow cytometry were studied in 53 patients with chronic renal failure who received continuous renal replacement therapy at the Hemodialysis Unit of the Chelyabinsk Regional Clinical Hospital.

全文:

受限制的访问

作者简介

M. Osikov

South Ural State Medical University

O. Gizinger

South Ural State Medical University

Email: ogizinger@gmail.com

L. Telesheva

South Ural State Medical University

Yu. Ageev

South Ural State Medical University

D. Cherepanov

South Ural State Medical University

A. Akleev

South Ural State Medical University

参考

  1. Волгина Г.В. Вторичный гиперпаратиреоз при хронической почечной недостаточности. Лечение активными метаболитами витамина D // Нефрология и диализ. - 2004; 6 (2): 116-24.
  2. Осиков М.В., Григорьев Т.А., Агеев Ю.И. Эфферентные и антиоксидантные свойства эритропоэтина при хронической почечной недостаточности // Эфферентная терапия. - 2011; 17 (4): 7-13.
  3. Осиков М.В., Григорьев Т.А., Федосов А.А. Роль эритропоэтина в реализации тромбоцитарно-клеточных взаимодействий в крови при хронической почечной недостаточности // Фундаментальные исследования. - 2012; 10-2: 285-9.
  4. Осиков М.В., Григорьев Т.А., Федосов А.А. Современные представления о гемостазиологических эффектах эритропоэтина // Фундаментальные исследования. - 2013; 5-1: 196-200.
  5. Betjes M., Immune cell dysfunction and inflammation in end-stage renal disease // Nat. Rev. Nephrol. - 2013; 5: 255-65.
  6. Carrero J., Stenvinkel P. Inflammation in end-stage renal disease-what have we learned in 10 years? // Semin. Dial. - 2010; 23: 498-509.
  7. Chung B., Kim K., Sun I. et al. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients // Immunol. Lett. - 2012; 141: 181-9.
  8. Cohen G., Hörl W. Immune Dysfunction in Uremia-An Update // Toxins (Basel). - 2012; 24 (4): 962-90.
  9. Eleftheriadis T., Kartsios C., Pissas G. et al. Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients // Ther. Apher. Dial. - 2013; 17 (1): 48-54.
  10. Eleftheriadis T., Yiannaki E., Antoniadi G. et al. Plasma indoleamine 2,3-dioxygenase and arginase type I may contribute to decreased blood T-cell count in hemodialysis patients // Ren. Fail. - 2012; 34 (9): 1118-22.
  11. Fernandez-Fresnedo G., Ramos M., Gonzalez-Pardo M. et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2 // Nephrol. Dial. Transplant. - 200; 15: 502-10.
  12. Kato S., Chmielewski M., Honda H. et al. Aspects of immune dysfunction in end-stage renal disease // Clin. J. Am. Soc. Nephrol. - 2008; 3 (5): 1526-33.
  13. Litjens N., Huisman M., van den Dorpel M. et al. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients // J. Am. Soc. Nephrol. - 2008; 19: 1483-90.
  14. Meier P., Golshayan D., Blanc E. et al. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD // J. Am. Soc. Nephrol. - 2009; 20: 1368-84.
  15. Meijers R., Litjens N., de Wit E. et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients // Immun. Ageing. -2012; 9 (1): 19.
  16. Pahl M., Gollapudi S., Sepassi L. et al. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression // Nephrol. Dial. Transplant. - 2010; 25: 205-12.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2014